DAVID
OTAEGUI BICHOT
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (7)
2022
-
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163
-
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis
Frontiers in Immunology, Vol. 13
-
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Journal of Neuroinflammation, Vol. 19, Núm. 1
2020
-
A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells
Journal of Clinical Medicine, Vol. 9, Núm. 3
-
Whole-transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal igm band characterization reveals two circular RNAs and two linear rnas as biomarkers of highly active disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-16
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
2014
-
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis
Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661